Biological Lattice Industries (BLI) Secures $1.8 Million Pre-Seed Funding Led by Uni.Fund to Democratize Biofabrication
18.10.2024 16:00:00 CEST | Business Wire | Press Release
Biological Lattice Industries Corp. (BLI), a leading innovator in biofabrication and life sciences R&D, today announced the successful closing of a $1.8 million pre-seed investment round led by Greek venture capital firm Uni.Fund. In conjunction with this funding announcement , BLI is introducing its first all-in-one solution for biofabrication: BioLoom™, BLI's advanced multi-tool 3D bioprinter and Loominus Studio™, its unified software platform designed to revolutionize biofabrication workflows.
BLI, a US startup with R&D operations in Greece, aims to radically simplify biofabrication for the global R&D community by providing intelligent, automated tools that streamline the design, fabrication, and testing of biomaterials. Biomaterials are critical for a wide array of biological applications. The applications range from advanced 3D cell culture systems for human biology emulation to the next-generation of resorbable medical devices and drug delivery systems for tissue trauma repair.
“We are thrilled to partner with Uni.Fund to bring our vision of democratizing biofabrication to life,” said Filippos Tourlomousis, Founder and CEO of BLI. “This funding will allow us to accelerate the development of our unified platform, enabling researchers to work with greater precision, reproducibility, and efficiency.”
Loominus Studio: A Unified Platform for Biofabrication
Current biofabrication workflows often require the coordination of multiple protocols, parameters and instruments, none of which are integrated. Loominus Studio™, BLI’s software offering, integrates every aspect of the biofabrication workflow, from design to fabrication. This all-in-one solution allows researchers to automate complex workflows, improving reproducibility and reducing the effort required to optimize biofabrication processes.
“Loominus Studio represents a new standard in biofabrication, allowing labs to focus on innovation rather than the technical challenges of integration,” said Filippos Tourlomousis. “Our goal is to make biofabrication as simple and intuitive as possible, empowering researchers to break through technical barriers.”
BioLoom™: Beyond Basic Bioprinting
At the core of BLI’s growing tool ecosystem is BioLoom™, a versatile multi-tool extrusion-based 3D bioprinter that can fabricate high-resolution multi-material architected scaffolds and devices. With its Active Environmental Control feature, BioLoom ensures reproducibility and supports Good Manufacturing Practice (GMP) compliance, making it ideal for labs focused on accelerating commercialization in life sciences.
“BioLoom provides an unparalleled level of versatility and precision,” added Tourlomousis. “It is designed to meet the needs of both academic and commercial labs, pushing the boundaries of biofabrication beyond traditional 3D bioprinting capabilities.”
The Role of Uni.Fund in Supporting Deep Tech Innovation
Uni.Fund, a venture capital firm committed to supporting world-class deep tech startups in Europe, sees BLI as a transformative force in biofabrication. “BLI is a game-changer in the biotech space, with a bold vision to disrupt how biofabrication is performed globally,” said Katerina Pramatari, Founding Partner at Uni.Fund. “Their integrated approach to life sciences R&D, combining sophisticated hardware and software powered by AI, is exactly the kind of innovation that Uni.Fund aims to support.”
Shaping the Future of Biofabrication Labs
With its ambitious vision, BLI aims to establish Loominus as the industry standard for biofabrication labs, offering a continuously growing array of tools and features that simplify complex workflows. The investment will accelerate the market availability of BioLoom and Loominus Studio that have already deployed to leading academic labs through the company’s early adopter’s customer program.
About Biological Lattice Industries (BLI)
Biological Lattice Industries Corp. (BLI) is a venture-backed startup founded in 2021 with the goal of democratizing biofabrication for life sciences R&D. BLI's platform, Loominus Studio, and its ecosystem of integrated hardware tools, including the BioLoom bioprinter, aim to revolutionize the way biomaterials are designed, fabricated, and tested.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241017262971/en/
Contacts
Media
info@biolattice.ai
Investor
Filippos Tourlomousis
filippos@biolattice.ai
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
COP31: World Cannot Afford Another Decade of Fossil Fuel Dependence as Climate Crisis Deepens8.11.2026 06:05:00 CET | Press Release
As world leaders prepare to gather in Antalya for COP31, 350.org is warning that the world cannot afford another decade of delay in transitioning away from fossil fuels. The UN climate conference starts amidst the largest fossil fuel crisis in history and people all over the world are facing increasingly devastating climate impacts while fossil fuel companies continue to rank obscene profits. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261107414423/en/ Ahead of COP31, 350 Türkiye raised a “Climate Justice, Now” banner at Antalya’s Kaleiçi Harbor, urging world leaders to commit to a just transition away from fossil fuels. Photo credit: Caner Özkan / 350.org 350.org is calling on the Turkish and Australian COP31 presidencies to build on this momentum and ensure that the summit delivers a credible pathway towards phasing out fossil fuels, backed by time bound milestones, accountability and finance. Governments must agree on
IntouchCX Recognized for Operations led AI and End to End CX Transformation by HFS Research6.11.2026 15:00:00 CET | Press Release
IntouchCX a global leader in AI-powered customer experience (CX) management, trust and safety, digital engagement, and back-office operations, has been positioned in the Horizon 2 end-to-end experience transformation, in the HFS Horizons Customer Experience Services 2026 report for its operations led approach to AI adoption and its model connecting advisory with delivery, from strategy through frontline executions. HFS Research evaluates customer experience service providers based on their capabilities, innovation, and potential to deliver value. The 2026 report examines how providers are helping businesses adopt AI, improve customer experiences and strengthen operations. “AI transformation delivers the greatest value when strategy, technology, and operations work together,” said Brent Stevenson, Chief Experience Officer at IntouchCX. “Our approach and expertise goes beyond technology. We identify business challenges and build the right solutions by connecting the dots between data, wo
The Estée Lauder Companies Unveils Mastering Skin Longevity, a Breakthrough Scientific Innovation Platform Advancing the Next Era of Skin Science6.11.2026 15:00:00 CET | Press Release
At the China International Import Expo (CIIE), The Estée Lauder Companies Inc. (NYSE: EL) today unveiled Mastering Skin Longevity, a breakthrough scientific innovation platform designed to advance the next era of skin science and transformative product innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261106776704/en/ The Estée Lauder Companies' Skin Longevity Clock serves as the visual representation for the Mastering Skin Longevity scientific innovation platform. Moving beyond the study of individual Hallmarks of Aging, the platform focuses further upstream on the Master Regulators of Skin Longevity. These interconnected biological pathways and proteins influence multiple hallmarks at once. By deepening understanding of these systems and how they help support skin’s ability to repair, adapt and regenerate, Mastering Skin Longevity will guide the Company’s discovery across ingredients, technologies, formulations an
Experian Named a Leader in 2026 IDC MarketScape for Worldwide Decision Intelligence Platforms6.11.2026 15:00:00 CET | Press Release
Experian today announced it has been named a Leader in the IDC MarketScape: Worldwide Decision Intelligence Platforms 2026 Vendor Assessment (Doc #US54118426, September 2026), which evaluates providers helping organizations design, engineer and orchestrate increasingly complex decisions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261106302874/en/ IDC MarketScape positions Experian as a Leader in its 2026 vendor assessment of worldwide decision intelligence platform providers. “As organizations embed AI into more consequential decisions, the combination of trusted data, advanced analytics and strong governance becomes increasingly important,” said Keith Little, President of Experian Software Solutions. “Experian brings those capabilities together with decisioning, fraud and identity to help organizations make better decisions with greater speed and confidence.” The Experian Ascend Platform provides a unified analytics and
Midas Atlantic Partners, i partnerskap med The Najafi Companies, har ingått ett putoptionsavtal med Sylvamo avseende ett potentiellt förvärv av Sylvamos europeiska verksamhet6.11.2026 12:05:00 CET | Pressmeddelande
Midas Atlantic Partners (”Midas Atlantic”), i partnerskap med The Najafi Companies, har ingått ett putoptionsavtal med Sylvamo Corporation (”Sylvamo”) avseende ett potentiellt förvärv av Sylvamos europeiska verksamhet (”Verksamheten”). Transaktionen omfattar Sylvamos bruk för obestruket träfritt papper i Saillat och Nymölla samt bolagets skogsverksamhet och stödjande affärsverksamhet i hela Europa. Transaktionen förväntas slutföras under första kvartalet 2027, efter att erforderliga samrådsprocesser har genomförts och myndighetsgodkännanden har erhållits. Verksamheten är en ledande europeisk tillverkare av obestruket träfritt papper för kontorsbruk och kommersiellt tryck. Produktportföljen omfattar kontorspapper i arkformat, som säljs under egna varumärken såsom REY och Multicopy samt för stora OEM-kunder och kunder inom kontorsmaterial, och pappersrullar för kommersiella tryckerier och konverterare. Verksamheten har sitt huvudkontor i Belgien och två storskaliga, vertikalt integrerade
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom